Quantcast

Latest Diabetes management Stories

2014-08-21 08:29:07

SAN DIEGO, Aug. 21, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company announced today that it has entered into a Rights Agreement with Janssen Research & Development LLC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01(TM) combination product that ViaCyte is developing for type 1 diabetes. This right will continue...

2014-08-19 23:14:17

Cure Diabetes Naturally, penned by Jacob Swilling, is a newly updated diabetes treatment guide that uncovers new methods for treating diabetes. The review of Cure Diabetes Naturally that was just posted by Vkool.com reveals if this book is worth buying. Seattle, WA (PRWEB) August 19, 2014 According to the Cure Diabetes Naturally review posted by Vkool.com, this is a newly updated diabetes treatment guide that uncovers new methods for treating high blood sugar levels. This book also...

2014-08-19 08:30:47

Company Plans to Immediately Initiate Phase 1/2 Clinical Trial SAN DIEGO, Aug. 19, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, announced today that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its VC-01(TM) candidate cell replacement therapy to treat type 1 diabetes. The company plans to promptly initiate a Phase 1/2 clinical trial which it believes to be the first...

2014-08-18 20:21:55

INDIANAPOLIS and RIDGEFIELD, Conn., Aug. 18, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today granted tentative approval for Basaglar(TM) (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes. Basaglar is not recommended for the treatment of diabetic ketoacidosis. Basaglar is Eli Lilly and Company (NYSE: LLY) and...

2014-08-15 16:23:17

Gmate® SMART connects with iPhone®, iPad® and iPod® touch to deliver accurate and fast blood glucose results NEW YORK, Aug. 15, 2014 /PRNewswire/ -- Philosys announces it has received U.S. Food and Drug Administration (FDA) 510K approval for the highly anticipated Gmate® SMART Blood Glucose Monitoring System. The Gmate® SMART meter is the size of a quarter and connects to the headphone jack on the iPhone, iPod touch or iPad, while using the free Gmate® SMART app to deliver...

40 Percent Of Americans Expected To Develop Type 2 Diabetes During Their Lifetime
2014-08-15 03:34:46

The Lancet Close to half (40%) of the adult population of the USA is expected to develop type 2 diabetes at some point during their lifetime, suggests a major study published in The Lancet Diabetes & Endocrinology. The future looks even worse for some ethnic minority groups, with one in two (> 50%) Hispanic men and women and non-Hispanic black women predicted to develop the disease. A team of US researchers combined data from nationally representative US population interviews...

2014-08-14 16:20:56

FORT KNOX, Ky., Aug. 14, 2014 /PRNewswire-USNewswire/ -- According to the American Diabetes Association, if current trends continue, one out of every three Americans could be diabetic by the year 2050. However, one Army doctor has made it his mission to halt the epidemic in its tracks. http://photos.prnewswire.com/prnvar/20140814/136290 Dr. Robert Vigersky is the head of the Diabetes Institute at Walter Reed National Military Medical Center, in Bethesda, Md. With a blend of civilian...

2014-08-14 08:29:59

Merkerson Visits Dallas, Texas on August 14 With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J., Aug. 14, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and actress S. Epatha Merkerson are bringing the America's Diabetes Challenge: Get to Your Goals program to Dallas, Texas to encourage African Americans with type 2 diabetes to know their A1C--their average blood sugar level over the past two to three...

2014-08-12 12:28:18

Company's Network and Technology Enable Trial of Artificial Pancreas in California NEW YORK, Aug. 12, 2014 /PRNewswire/ -- Kids and teens with Type 1 diabetes are swimming, rock climbing, hiking and playing various field sports in the redwoods of the Santa Cruz Mountains - all while testing a device that automatically measures their blood sugar and determines how much insulin they'll need. Using Verizon's network technology, campers aged 7 to 17 are participating in a clinical...

2014-08-12 08:31:09

New study adds to a growing body of evidence supporting benefits of tree nut consumption on measures of glycemic control in people with diabetes and metabolic syndrome MODESTO, Calif., Aug. 12, 2014 /PRNewswire/ -- Evidence continues to mount supporting the role of almonds and other tree nuts as part of an overall dietary pattern that is beneficial for those with type 2 diabetes. Three new studies suggest a relationship between regular consumption of tree nuts, such as almonds, and...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related